Variant report

Variant	esv3366386
Chromosome Location	chr5:167717474-167720872
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr5:167718294-167718578	HepG2	liver:	n/a	n/a
2	ATF2	chr5:167718199-167718704	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr5:167718169-167718764	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCL3	chr5:167718104-167718774	A549	lung:	n/a	n/a
5	BCL3	chr5:167717995-167718746	A549	lung:	n/a	n/a
6	BCLAF1	chr5:167718532-167718956	GM12878	blood:	n/a	chr5:167718939-167718952 chr5:167718936-167718949
7	BHLHE40	chr5:167718313-167718783	HepG2	liver:	n/a	chr5:167718686-167718702
8	BHLHE40	chr5:167718584-167718792	GM12878	blood:	n/a	chr5:167718686-167718702
9	BRCA1	chr5:167718331-167718725	Hela-S3	cervix:	n/a	n/a
10	CBX3	chr5:167717974-167719000	HCT-116	colon:	n/a	n/a
11	CEBPB	chr5:167718009-167718689	A549	lung:	n/a	n/a
12	CEBPB	chr5:167718142-167718405	HepG2	liver:	n/a	n/a
13	CEBPB	chr5:167718103-167718818	Hela-S3	cervix:	n/a	n/a
14	CEBPB	chr5:167718155-167718651	H1-hESC	embryonic stem cell:	n/a	n/a
15	CEBPB	chr5:167718155-167718704	A549	lung:	n/a	n/a
16	CEBPD	chr5:167719432-167719632	HepG2	liver:	n/a	n/a
17	CEBPD	chr5:167718455-167718807	HepG2	liver:	n/a	n/a
18	CHD1	chr5:167718572-167718795	H1-hESC	embryonic stem cell:	n/a	n/a
19	CHD2	chr5:167719893-167720091	Hela-S3	cervix:	n/a	n/a
20	CHD2	chr5:167718454-167718833	HepG2	liver:	n/a	n/a
21	CHD2	chr5:167718389-167718782	GM12878	blood:	n/a	n/a
22	CHD2	chr5:167718042-167718760	H1-hESC	embryonic stem cell:	n/a	n/a
23	CHD2	chr5:167718128-167719602	Hela-S3	cervix:	n/a	chr5:167719438-167719448 chr5:167719413-167719423 chr5:167718942-167718952
24	CREB1	chr5:167718279-167718900	A549	lung:	n/a	n/a
25	CTCF	chr5:167718440-167718590	AoAF	blood vessel:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
26	CTCF	chr5:167718460-167718610	Caco-2	colon:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
27	CTCF	chr5:167719360-167719510	AoAF	blood vessel:	n/a	n/a
28	CTCF	chr5:167718240-167718390	BJ	skin:	n/a	n/a
29	CTCF	chr5:167719300-167719450	GM12878	blood:	n/a	n/a
30	CTCF	chr5:167719400-167719550	HRE	kidney:	n/a	n/a
31	CTCF	chr5:167719400-167719550	AG10803	skin:	n/a	n/a
32	CTCF	chr5:167718460-167718610	AG09319	gingival:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
33	CTCF	chr5:167719360-167719510	GM12868	blood:	n/a	n/a
34	CTCF	chr5:167719340-167719490	HEK293	kidney:	n/a	n/a
35	CTCF	chr5:167719300-167719450	AG04449	skin:	n/a	n/a
36	CTCF	chr5:167718540-167718690	HCM	heart:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
37	CTCF	chr5:167718380-167718530	HMF	breast:	n/a	n/a
38	CTCF	chr5:167718448-167718620	SK-N-SH_RA	brain:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
39	CTCF	chr5:167718480-167718630	WERI-Rb-1	eye:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
40	CTCF	chr5:167719760-167719910	Hela-S3	cervix:	n/a	n/a
41	CTCF	chr5:167718540-167718880	LNCaP	prostate:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
42	CTCF	chr5:167718460-167718610	BJ	skin:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
43	CTCF	chr5:167718311-167718944	H1-hESC	embryonic stem cell:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
44	CTCF	chr5:167718400-167718550	HBMEC	blood vessel:	n/a	n/a
45	CTCF	chr5:167718640-167718790	GM12871	blood:	n/a	n/a
46	CTCF	chr5:167718460-167718874	GM19240	blood:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
47	CTCF	chr5:167718500-167718650	Caco-2	colon:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
48	CTCF	chr5:167718471-167718838	Pancreas_OC	pancreas:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
49	CTCF	chr5:167718461-167718629	A549	lung:	n/a	chr5:167718555-167718565 chr5:167718551-167718567 chr5:167718553-167718566 chr5:167718553-167718566
50	CTCF	chr5:167719400-167719550	GM12870	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:167719478-167719528	AG10803	skin:	n/a
2	chr5:167718483-167718533	NHBE	bronchial:	n/a
3	chr5:167718124-167718174	PFSK-1	brain:	n/a
4	chr5:167719548-167719598	HCF	heart:	n/a
5	chr5:167718524-167718574	HAEpiC	amniotic membrane:	n/a
6	chr5:167719214-167719264	RPTEC	kidney:	n/a
7	chr5:167719478-167719528	PFSK-1	brain:	n/a
8	chr5:167719742-167719792	GM12891	blood:	n/a
9	chr5:167719548-167719598	HepG2	liver:	n/a
10	chr5:167719742-167719792	MCF10A-Er-Src	breast:	n/a
11	chr5:167718124-167718174	GM12878	blood:	n/a
12	chr5:167719742-167719792	AG10803	skin:	n/a
13	chr5:167718982-167719032	GM06990	blood:	n/a
14	chr5:167718496-167718546	PFSK-1	brain:	n/a
15	chr5:167719548-167719598	CMK	blood:	n/a
16	chr5:167718124-167718174	HRCEpiC	kidney:	n/a
17	chr5:167719687-167719737	NH-A	brain:	n/a
18	chr5:167718982-167719032	MCF10A-Er-Src	breast:	n/a
19	chr5:167719262-167719312	LNCaP	prostate:	n/a
20	chr5:167719262-167719312	GM12892	blood:	n/a
21	chr5:167718982-167719032	HCT-116	colon:	n/a
22	chr5:167718536-167718586	NHDF-neo	bronchial:	n/a
23	chr5:167718536-167718586	HMEC	breast:	n/a
24	chr5:167719548-167719598	Caco-2	colon:	n/a
25	chr5:167718536-167718586	A549	lung:	n/a
26	chr5:167719687-167719737	HAEpiC	amniotic membrane:	n/a
27	chr5:167719262-167719312	ovcar-3	ovarian:	n/a
28	chr5:167718496-167718546	ECC-1	luminal epithelium:	n/a
29	chr5:167719214-167719264	PFSK-1	brain:	n/a
30	chr5:167718536-167718586	SK-N-MC	brain:	n/a
31	chr5:167718982-167719032	CMK	blood:	n/a
32	chr5:167718483-167718533	ProgFib	skin:	n/a
33	chr5:167718496-167718546	HEEpiC	esophagus:	n/a
34	chr5:167718496-167718546	T-47D	breast:	n/a
35	chr5:167718483-167718533	RPTEC	kidney:	n/a
36	chr5:167718483-167718533	GM12891	blood:	n/a
37	chr5:167718524-167718574	SKMC	muscle:	n/a
38	chr5:167719478-167719528	HUVEC	blood vessel:	n/a
39	chr5:167718536-167718586	SK-N-SH	brain:	n/a
40	chr5:167718536-167718586	HepG2	liver:	n/a
41	chr5:167719742-167719792	HRCEpiC	kidney:	n/a
42	chr5:167718124-167718174	HCF	heart:	n/a
43	chr5:167719548-167719598	NHDF-neo	bronchial:	n/a
44	chr5:167718496-167718546	HCPEpiC	choroid plexus:	n/a
45	chr5:167718124-167718174	BJ	skin:	n/a
46	chr5:167718536-167718586	PFSK-1	brain:	n/a
47	chr5:167718496-167718546	HepG2	liver:	n/a
48	chr5:167719262-167719312	HEEpiC	esophagus:	n/a
49	chr5:167718483-167718533	MCF10A-Er-Src	breast:	n/a
50	chr5:167719742-167719792	LNCaP	prostate:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:167703411..167705760-chr5:167716598..167718533,2	MCF-7	breast:
2	chr5:167696952..167697760-chr5:167717873..167718444,2	MCF-7	breast:
3	chr5:167719706..167722622-chr5:167894559..167896628,2	MCF-7	breast:
4	chr5:167716529..167718566-chr5:167880589..167883099,2	MCF-7	breast:
5	chr5:167715928..167721153-chr5:167739241..167745348,16	MCF-7	breast:
6	chr5:167718914..167721325-chr5:167913985..167916640,3	MCF-7	breast:
7	chr5:167720610..167721433-chr5:167743019..167743616,2	MCF-7	breast:
8	chr5:167720165..167722660-chr5:167828436..167831193,2	MCF-7	breast:
9	chr5:167718826..167719451-chrX:153626634..153627161,2	Hela-S3	cervix:
10	chr5:167718924..167721617-chr5:168004476..168006374,2	MCF-7	breast:

Variant related genes	Relation type
WWC1	TF binding region
WWC1	CpG island
ENSG00000120137	chromatin interactions
ENSG00000147403	chromatin interactions
ENSG00000113645	chromatin interactions
ENSG00000113643	chromatin interactions

Extended variants
information (count: 108 )
Associated
traits (count: 86 )

Variant overlapped rSNPs/rCNVs (count:108 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs572517659	chr5:167717521-167717522	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs541615307	chr5:167717546-167717547	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs200096973	chr5:167717578-167717579	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs559948374	chr5:167717579-167717580	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs138978948	chr5:167717593-167717594	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs371028691	chr5:167717678-167717679	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs549129870	chr5:167717687-167717688	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs562453689	chr5:167717709-167717710	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs34562855	chr5:167717715-167717716	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs10475874	chr5:167717734-167717735	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs556359596	chr5:167717754-167717755	Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs143690548	chr5:167717803-167717804	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs571523171	chr5:167717811-167717812	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs149548451	chr5:167717822-167717823	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs533709121	chr5:167717863-167717864	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs547561056	chr5:167717911-167717912	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
17	rs567394966	chr5:167717951-167717952	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs536324040	chr5:167717961-167717962	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs370613388	chr5:167717981-167717982	Active TSS Weak transcription Enhancers Flanking Active TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs569679344	chr5:167718018-167718019	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
21	rs538667240	chr5:167718048-167718049	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs72838318	chr5:167718060-167718061	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
23	rs546705787	chr5:167718074-167718075	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
24	rs572706706	chr5:167718081-167718082	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs571364420	chr5:167718122-167718123	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs541399334	chr5:167718132-167718133	Active TSS Weak transcription Enhancers Bivalent/Poised TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs555125670	chr5:167718245-167718246	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs575121487	chr5:167718273-167718274	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs542712789	chr5:167718282-167718283	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs562596040	chr5:167718290-167718291	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs531285803	chr5:167718368-167718369	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs187589030	chr5:167718397-167718398	Active TSS Flanking Active TSS Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs564770360	chr5:167718442-167718443	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs374032750	chr5:167718452-167718453	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs12655262	chr5:167718512-167718513	Active TSS Flanking Active TSS Bivalent Enhancer Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
36	rs370211667	chr5:167718649-167718650	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs547402867	chr5:167718666-167718667	Active TSS Flanking Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs567106327	chr5:167718803-167718804	Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs529854764	chr5:167718834-167718835	Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs12653143	chr5:167718848-167718849	Active TSS Transcr. at gene 5' and 3' Enhancers Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs549835218	chr5:167719041-167719042	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
42	rs569815903	chr5:167719066-167719067	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
43	rs200626560	chr5:167719141-167719142	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
44	rs4634370	chr5:167719143-167719144	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
45	rs375703595	chr5:167719152-167719153	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
46	rs370421132	chr5:167719153-167719154	Active TSS Enhancers Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
47	rs535312961	chr5:167719204-167719205	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
48	rs374092809	chr5:167719240-167719241	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
49	rs200146764	chr5:167719247-167719248	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island Chromatin interactive region	5 gene(s)	Overlapped CNVs	n/a
50	rs376695378	chr5:167719268-167719269	Active TSS Weak transcription Enhancers Flanking Active TSS Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:86)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Multiple myeloma	17550852	CNVD
Acute myeloid leukemia	21251322	CNVD
Salivary gland tumor	18059337	CNVD
Renal cell carcinoma	19377443	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Renal cell carcinoma	18592004	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	21720365	CNVD
Olfactory neuroblastoma	18408657	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mental retardation	17124404	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16865294	CNVD
Sotos syndrome	21572526	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Sotos syndrome	17561922	CNVD
Sotos syndrome	16773131	CNVD
Mental retardation	16773131	CNVD
Sotos syndrome	22470819	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Epilepsy	20502679	CNVD
Melanoma	20877625	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:485 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:167704600-167718000	Weak transcription	Pancreatic Islets	Pancreatic Islet
2	chr5:167709600-167718000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr5:167709600-167718000	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr5:167709600-167718000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
5	chr5:167712600-167718400	Weak transcription	Gastric	stomach
6	chr5:167713000-167718000	Enhancers	Fetal Brain Male	brain
7	chr5:167713200-167718200	Weak transcription	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr5:167713400-167717800	Weak transcription	H9 Cell Line	embryonic stem cell
9	chr5:167713400-167718000	Enhancers	GM12878-XiMat	blood
10	chr5:167713600-167718000	Weak transcription	Cortex derived primary cultured neurospheres	brain
11	chr5:167713600-167718000	Enhancers	Placenta	Placenta
12	chr5:167713800-167717800	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
13	chr5:167713800-167718000	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
14	chr5:167714000-167718200	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
15	chr5:167714600-167718200	Enhancers	Fetal Intestine Small	intestine
16	chr5:167715800-167718000	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
17	chr5:167715800-167718000	Weak transcription	Brain Anterior Caudate	brain
18	chr5:167715800-167718000	Weak transcription	Colonic Mucosa	Colon
19	chr5:167715800-167718000	Weak transcription	Esophagus	oesophagus
20	chr5:167715800-167718200	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
21	chr5:167716000-167718000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
22	chr5:167716200-167717800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
23	chr5:167716200-167717800	Weak transcription	HUES64 Cell Line	embryonic stem cell
24	chr5:167716200-167717800	Enhancers	Breast Myoepithelial Primary Cells	Breast
25	chr5:167716200-167717800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
26	chr5:167716200-167718000	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
27	chr5:167716200-167718000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
28	chr5:167716200-167718000	Enhancers	Liver	Liver
29	chr5:167716200-167718000	Weak transcription	Fetal Lung	lung
30	chr5:167716200-167718000	Enhancers	HMEC	breast
31	chr5:167716200-167718200	Weak transcription	Placenta Amnion	Placenta Amnion
32	chr5:167716200-167718200	Weak transcription	Rectal Mucosa Donor 31	rectum
33	chr5:167716400-167717800	Enhancers	HepG2	liver
34	chr5:167716400-167718000	Enhancers	Hela-S3	cervix
35	chr5:167716400-167718000	Enhancers	NHEK	skin
36	chr5:167716400-167718200	Weak transcription	NH-A	brain
37	chr5:167716600-167717800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
38	chr5:167717000-167717800	Enhancers	iPS-20b Cell Line	embryonic stem cell
39	chr5:167717000-167718200	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
40	chr5:167717200-167717800	Enhancers	H1 Cell Line	embryonic stem cell
41	chr5:167717200-167718000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
42	chr5:167717200-167718000	Enhancers	Fetal Kidney	kidney
43	chr5:167717200-167718000	Weak transcription	Stomach Mucosa	stomach
44	chr5:167717200-167718200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
45	chr5:167717200-167718200	Enhancers	HSMMtube	muscle
46	chr5:167717400-167717800	Weak transcription	Fetal Intestine Large	intestine
47	chr5:167717400-167717800	Weak transcription	Pancreas	Pancrea
48	chr5:167717400-167717800	Enhancers	A549	lung
49	chr5:167717400-167718000	Weak transcription	Primary B cells from peripheral blood	blood
50	chr5:167717400-167718000	Enhancers	Fetal Brain Female	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links